MONDAY, MAY 22, 2017

Multi-tasking flu vaccine may offer improved protection

Australian researchers recently discovered a method of improving the efficacy and cross-protective abilities of a vaccine for influenza A by adding one component. Read More »

Federal government awards Ryan White grants to HIV care providers

The U.S. Department of Health and Human Services (HHS) recently gave over $2.2 billion in grants from the Ryan White HIV/AIDS Program to states, cities and community-based organizations for HIV/AIDS care and medications. Read More »

USAID offers help for TB patients in more than 100 countries

The United States Agency for International Development (USAID) recently announced that it is providing life-saving medicine  in more than 100 countries for patients who have drug-resistant tuberculosis (TB). Read More »

U.S. Department of Health funds novel methods of improving influenza vaccines

The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) recently provided sponsorship of two novel approaches to improving influenza vaccines. Read More »

Study finds HIV particles trapped more effectively by certain cervicovaginal mucus

Findings of a recent study indicating that HIV particles are more effectively trapped by the cervicovaginal mucus (CVM) in women who harbor the vaginal bacteria species Lactobacillus crispatus were published Tuesday in mBio, the open access journal of the American Society for Microbiology (ASM).  Read More »

PAHO leaders plan to increase immunization rates, reduce deaths from tuberculosis, hepatitis

Health leaders who plan to attend the 54th Directing Council of the Pan American Health Organization (PAHO) have put in place plans and methods to increase immunization rates, reduce deaths and illness from hepatitis, step up the fight against tuberculosis (TB) and update public health laws in the Americas. Read More »

HHS unit sponsoring development of drug for severe flu cases

The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) is sponsoring a drug being developed to treat patients hospitalized with severe cases of influenza. the Biomedical Advanced Research and Development Authority (BARDA) said this week. Read More »

Pneumococcal and rotavirus vaccines to decrease pediatric hospitalization

Scientists recently conducted a study to demonstrate that introducing both pneumococcal conjugate vaccines (PCVs) as well as rotavirus vaccines (RVs) helped to reduce the hospital burden of respiratory infections and winter diarrhea. Read More »

Children with cerebral malaria show novel disease signatures

Researchers recently discovered that children who have cerebral malaria have novel signatures of the disease in their brains. Read More »

Antiviral drugs in silicone vaginal rings protect women from HIV

Scientists from the University Jean Monnet of Saint-Etienne, France, recently announced that they have successfully created a vaginal silicone ring that delivers antiviral drugs to protect women from both HIV and herpes. Read More »

Women-only HIV study improves understanding of effective, safe antiretroviral treatments

Researchers recently presented the results from the first phase 3 HIV study that recruited only women to demonstrate the improved efficacy and safety of Stribild compared to multi-pill antiretroviral drug regimens. Read More »

Johns Hopkins team improves protective wear for health workers

The Johns Hopkins University's new personal protective suit for health care workers in Ebola outbreaks was recognized this month as one of 10 finalists in the Social Good category of Fast Company's 2015 Innovation by Design Awards. Read More »

HHS program advances experimental Ebola vaccine regimen

An experimental Ebola vaccine regimen recently succeeded in making progress, thanks to an agreement between the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) and Crucell Holland, BV, which is a branch of the Janssen Pharmaceutical Companies under Johnson & Johnson. Read More »

Gupta stresses vaccinations at New Delhi Call to Action Summit

Gavi’s Deputy CEO Anuradha Gupta and other global health leaders met last week at the Call to Action Summit to discuss their commitment to ending infant and maternal mortality through immunizations. Read More »

D.C. needle exchange program prevents 120 HIV cases in two years

The needle exchange program in the District of Columbia has reportedly prevented 120 new HIV infection cases in just over two years. Read More »

Eureka Prize goes to hepatitis B cure

A team from the Walter and Eliza Hall Institute has earned the 2015 Australian Museum Eureka Prize for Infectious Disease Research for their search for a hepatitis B cure. Read More »

Study shows influenza vaccines offer moderate protection during flu season

A recent study shows that people who accepted the influenza vaccine had moderate protection against the flu for the duration of the entire flu season, up to six months, the American Society for Microbiology said Tuesday. Read More »

Cell phone data to monitor spread of infectious diseases

Vast datasets from tracking mobile phone data could allow health professionals to track the infectious diseases that spread each season. Read More »

Singapore General Hospital, 60 Degrees Pharmaceuticals advance dengue fever clinical trials

Singapore General Hospital and 60 Degrees Pharmaceuticals (60P), a company specializing in developing therapeutics specifically for tropical diseases, recently announced that it will soon launch a Phase II clinical trial for patients who have dengue fever. Read More »

Global initiative for river blindness vaccine strengthens in Africa

The Sabin Vaccine Institute Product Development Partnership (Sabin PDP) recently became an advocate of The Onchocerciasis Vaccine for Africa (TOVA) Initiative, which is dedicated to creating a vaccine for onchocerciasis. Read More »